Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease
Graft versus host disease (GVHD) is the major non-relapse complication associated with allogeneic hematopoietic stem cell transplantation (HSCT). Unfortunately, GVHD occurs in roughly half of patients following this therapy and can induce severe life-threatening side effects and premature mortality....
Guardado en:
Autores principales: | Aditya Rayasam, William R. Drobyski |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a102fdc62b844ae9b9c5a472aef56059 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
por: Takahashi,Hiroshi, et al.
Publicado: (2015) -
Ruxolitinib for Treatment of Steroid-Refractory Graft-versus-Host Disease: Real-World Data from Chinese Patients
por: Wei C, et al.
Publicado: (2021) -
Sirolimus versus imatinib in patients with steroid-refractory chronic graft-versus-host disease: a retrospective analysis of a single-center
por: HE Yundi, et al.
Publicado: (2021) -
Effect and mechanism of human umbilical cord mesenchymal stem cells on preventing murine acute graft-versus-host disease
por: HONG Tao, et al.
Publicado: (2021) -
Letermovir Prophylaxis and Cytomegalovirus Reactivation in Adult Hematopoietic Cell Transplant Recipients with and without Acute Graft Versus Host Disease
por: Delaney Wolfe, et al.
Publicado: (2021)